Companies House true 2023-01-01 2023-12-25 true 13059073 uk-bus:Director1 2023-01-01 2023-12-25 13059073 uk-bus:Director2 2023-01-01 2023-12-25 13059073 2023-01-01 2023-12-25 13059073 2023-12-25 13059073 uk-bus:EntityHasNeverTraded 2023-01-01 2023-12-25 13059073 uk-bus:FRS102 2023-01-01 2023-12-25 13059073 uk-bus:FullAccounts 2023-01-01 2023-12-25 13059073 uk-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-25 13059073 2022-12-31 13059073 uk-bus:OrdinaryShareClass1 2023-01-01 2023-12-25 13059073 uk-bus:OrdinaryShareClass2 2023-01-01 2023-12-25 13059073 uk-bus:OrdinaryShareClass3 2023-01-01 2023-12-25 13059073 uk-bus:PreferenceShareClass1 2023-01-01 2023-12-25 13059073 uk-bus:PreferenceShareClass2 2023-01-01 2023-12-25 13059073 uk-bus:PreferenceShareClass3 2023-01-01 2023-12-25 13059073 uk-core:ShareCapitalPreferenceShares 2023-12-25 13059073 uk-core:ShareCapitalPreferenceShares 2022-12-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 13059073

PRONEX PHARMA LIMITED

Dormant Accounts

25 December 2023

PRONEX PHARMA LIMITED Registered Number 13059073

Balance Sheet as at 25 December 2023

2023 2022
£ £
Called up share capital not paid
1
1
Net assets
1
1
Issued share capital
1 1 Share of £ 1 each 1 1
Total Shareholder funds
1
1

STATEMENTS

  1. For the year ending 25 December 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 25 December 2023

And signed on their behalf by:
Haider Samaka, Director

NOTES

During the year the company acted as an agent for a person